Results 1 to 10 of about 3,567,846 (194)
Extended Generalized DoF Optimality Regime of Treating Interference as Noise in the X Channel [PDF]
The simple scheme of treating interference as noise (TIN) is studied in this paper for the 3 x 2 X channel. A new sum-capacity upper bound is derived. This upper bound is transformed into a generalized degrees-of-freedom (GDoF) upper bound, and is shown to coincide with the achievable GDoF of scheme that combines TDMA and TIN for some conditions on the
Soheil Gherekhloo+2 more
arxiv +3 more sources
Treat & extend versus PRN in AMD
SummaryBasically 3 different approaches to anti‐VEGF treatment in AMD are in clinical use, a fixed regimen using monthly or bi‐monthly injections (IVI), a PRN strategy and a Treat and Extend (T&E) regimen.T&E is a proactive and individualized anti‐VEGF treatment regimen. Basically IVI are performed monthly until stability is achieved.
Christian Pruente
openaire +3 more sources
Age, Initial Central Retinal Thickness, and OCT Biomarkers Have an Influence on the Outcome of Diabetic Macular Edema Treated With Ranibizumab– Tri-center 12-Month Treat-and-Extend Study [PDF]
Objective: We report the tri-center 1-year outcomes of a treat-and-extend (T&E) regimen in four-week intervals with ranibizumab for diabetic macular edema (DME).Methods: In this retrospective study, all eyes received 3 monthly loading injections of 0.
Chun-Ting Lai+14 more
doaj +2 more sources
Myasthenia Gravis with Membranous Nephropathy, Successfully Treated with Extended Total Thymectomy.
A 46-year-old woman showed proteinuria and hematuria after left blepharoptosis, and revealed a histopathology of membranous nephropathy (MN) at renal biopsy. She was diagnosed as having myasthenia gravis (MG) because of a positive edrophonium test and anti-acetylcholine receptor (AchR) antibodies in serum.
Hiroki Ishigame+5 more
openaire +5 more sources
Multicentric Cardiac Myxoma Treated with Extended Surgery [PDF]
We present the case of a 37-year-old male patient with a multicentric myxoma admitted to hospital with dyspnoea, syncope and chest pain. Physical examination revealed a grade 3/6 systolic murmur at the left lower sternal border and diffuse bilateral lung rales.
Cengiz, M., Gurbuz, O., Yilmaz, M.
openaire +4 more sources
Background To assess the morphological and functional outcome of intravitreal aflibercept following the treat and extend protocol compared to the fixed protocol for treatment of eyes with neovascular age-related macular degeneration.
Alaa Din Abdin+6 more
doaj +1 more source
The use of anti-vascular-endothelial growth factor agents for neovascular age-related macular degeneration (nAMD) in different treatment schemes is widely common in clinical practice.
Laura Hoffmann, Katja Hatz, Katja Hatz
doaj +1 more source
Long-term Outcomes of Treat and Extend Regimen of Anti-vascular Endothelial Growth Factor in Neovascular Age-related Macular Degeneration [PDF]
Purpose: This study describes the long-term visual and anatomic outcomes of antivascular endothelial growth factor (VEGF) treatment using a treat and extend dosing regimen.
G Garg, Pooja+4 more
core +3 more sources
Background To evaluate the three-year outcome after intravitreal aflibercept injection (IAI) for neovascular age-related macular degeneration (nAMD). Methods Forty-nine treatment-naïve nAMD patients (50 eyes) were enrolled in this prospective study.
Kanako Itagaki+5 more
doaj +1 more source
Purpose To investigate the visual and anatomical outcomes associated with treat-and-extend (TAE) regimen of intravitreal (IVT) aflibercept in eyes with treatment naïve neovascular age-related macular degeneration (nvAMD).
Mohamed Kamel Soliman+4 more
doaj +1 more source